Discontinuation report MYLAN-OMEPRAZOLE
Report ID | 48569 |
Drug Identification Number | 02329433 |
Brand name | MYLAN-OMEPRAZOLE |
Common or Proper name | OMEPRAZOLE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | OMEPRAZOLE |
Strength(s) | 20MG |
Dosage form(s) | CAPSULE (DELAYED RELEASE) |
Route of administration | ORAL |
Packaging size | 100BT, 500BT |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2018-05-01 |
Remaining supply date | 2018-05-01 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Discontinued in shortage ID 19496. Last Lot # 3080647 Expires 31-Mar-18 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2018-05-04 | French | Compare |
v1 | 2018-05-04 | English | Compare |
Showing 1 to 2 of 2